These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17353777)

  • 21. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
    Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
    Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin.
    Wetzig T; Sticherling M; Simon JC; Hegenbart U; Niederwieser D; Al-Ali HK
    Bone Marrow Transplant; 2005 Mar; 35(5):515-9. PubMed ID: 15665847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease.
    Perales MA; Ishill N; Lomazow WA; Weinstock DM; Papadopoulos EB; Dastigir H; Chiu M; Boulad F; Castro-Malaspina HR; Heller G; Jakubowski AA; O'Reilly RJ; Small TN; Young JW; Kernan NA
    Bone Marrow Transplant; 2007 Sep; 40(5):481-6. PubMed ID: 17618322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and manifestations of chronic graft-versus-host disease.
    Filipovich AH
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):251-7. PubMed ID: 18503990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eosinophilic gastroenteritis in a young girl--long term remission under Montelukast.
    Quack I; Sellin L; Buchner NJ; Theegarten D; Rump LC; Henning BF
    BMC Gastroenterol; 2005 Jul; 5():24. PubMed ID: 16026609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
    Kuruvilla J; Shepherd JD; Sutherland HJ; Nevill TJ; Nitta J; Le A; Forrest DL; Hogge DE; Lavoie JC; Nantel SH; Toze CL; Smith CA; Barnett MJ; Song KW
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):925-31. PubMed ID: 17640596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of acute graft-versus-host disease with PUVA (psoralen and ultraviolet irradiation): results of a pilot study.
    Wiesmann A; Weller A; Lischka G; Klingebiel T; Kanz L; Einsele H
    Bone Marrow Transplant; 1999 Jan; 23(2):151-5. PubMed ID: 10197800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
    Koh LP; Chen CS; Tai BC; Hwang WY; Tan LK; Ng HY; Linn YC; Koh MB; Goh YT; Tan B; Lim S; Lee YM; Tan KW; Liu TC; Ng HJ; Loh YS; Mow BM; Tan DC; Tan PH
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):790-805. PubMed ID: 17580257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial reconstitution of cutaneous microvessels in long-term survivors after allogeneic bone marrow transplantation.
    Haeusermann P; Kump E; Rovó A; Tichelli A; Itin P; Gratwohl A; Biedermann BC
    Dermatology; 2009; 219(1):32-41. PubMed ID: 19407437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease.
    Jurado M; Vallejo C; Pérez-Simón JA; Brunet S; Ferra C; Balsalobre P; Pérez-Oteyza J; Espigado I; Romero A; Caballero D; Sierra J; Ribera JM; Díez JL
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):701-6. PubMed ID: 17531780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema.
    Friedmann PS; Palmer R; Tan E; Ogboli M; Barclay G; Hotchkiss K; Berth-Jones J
    Clin Exp Allergy; 2007 Oct; 37(10):1536-40. PubMed ID: 17850382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
    Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulse cyclophosphamide for corticosteroid-refractory graft-versus-host disease.
    Mayer J; Krejcí M; Doubek M; Pospísil Z; Brychtová Y; Tomíska M; Rácil Z
    Bone Marrow Transplant; 2005 Apr; 35(7):699-705. PubMed ID: 15696180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
    Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Daclizumab for children with corticosteroid refractory graft-versus-host disease.
    Teachey DT; Bickert B; Bunin N
    Bone Marrow Transplant; 2006 Jan; 37(1):95-9. PubMed ID: 16247417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How can we help patients with refractory chronic graft versus host disease- single centre experience.
    Rzepecki P; Barzal J; Sarosiek T; Oborska S; Szczylik C
    Neoplasma; 2007; 54(5):431-6. PubMed ID: 17688373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous graft-versus-host disease: a guide for the dermatologist.
    Häusermann P; Walter RB; Halter J; Biedermann BC; Tichelli A; Itin P; Gratwohl A
    Dermatology; 2008; 216(4):287-304. PubMed ID: 18230976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement in vulvar vestibulitis with montelukast.
    Kamdar N; Fisher L; MacNeill C
    J Reprod Med; 2007 Oct; 52(10):912-6. PubMed ID: 17977165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-line therapy for chronic graft-versus-host disease that includes low-dose methotrexate is associated with a high response rate.
    Wang Y; Xu LP; Liu DH; Chen H; Chen YH; Han W; Liu KY; Huang XJ
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):505-11. PubMed ID: 19285639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.